Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.
- DOI
- 10.1007/s12325-025-03244-1
- Published
- 2025 Sep
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-025-03244-1,
title = {Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.},
author = {Taylor PC and Bieber T and Alten R and Witte T and Galloway J and Deberdt W and Issa M and Haladyj E and De La Torre I and Grond S and Wollenberg A},
year = {2025},
journal = {Advances in therapy},
doi = {10.1007/s12325-025-03244-1},
url = {https://doi.org/10.1007/s12325-025-03244-1}
}RIS
TY - JOUR TI - Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications. AU - Taylor PC AU - Bieber T AU - Alten R AU - Witte T AU - Galloway J AU - Deberdt W AU - Issa M AU - Haladyj E AU - De La Torre I AU - Grond S AU - Wollenberg A PY - 2025 JO - Advances in therapy DO - 10.1007/s12325-025-03244-1 UR - https://doi.org/10.1007/s12325-025-03244-1 ER -
APA
PC, T., T, B., R, A., T, W., J, G., W, D., M, I., E, H., I, D. L. T., S, G., & A, W. (2025). Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.. Advances in therapy. https://doi.org/10.1007/s12325-025-03244-1
Source records
- pubmed · retrieved 2026-09-26T08:03:51.645Z